SBF2 and glioma: Consistent to our result, it has been revealed that reduced SBF2-AS1 could decelerate the tumor growth of acute myeloid leukemia in vivo [26], and it has been unveiled that overexpressed miR-143 served as a tumor repressor in glioma [32].